21![Engineering Next-Generation Therapeutic Proteins: Trends and Markets toExecutive Summary Executive Summary Engineering Next-Generation Therapeutic Proteins: Trends and Markets toExecutive Summary Executive Summary](https://www.pdfsearch.io/img/7c7e43d98cfdc1a1dd0d54f9717f6c34.jpg) | Add to Reading ListSource URL: www.insightpharmareports.comLanguage: English - Date: 2011-08-03 14:46:23
|
---|
22![Fusion Antibodies and C-Term Diagnostics develop novel in vitro diagnostic products C-Term and Fusion Antibodies have been working together for more than two years and have successfully developed highly specific antibodi Fusion Antibodies and C-Term Diagnostics develop novel in vitro diagnostic products C-Term and Fusion Antibodies have been working together for more than two years and have successfully developed highly specific antibodi](https://www.pdfsearch.io/img/2a02797d6cf766df0b56626f31b511e0.jpg) | Add to Reading ListSource URL: www.prweb.comLanguage: English - Date: 2014-08-13 03:00:37
|
---|
23![To
search
patents
or
to
not
To
search
patents
or
to
not](https://www.pdfsearch.io/img/fcc826a7367fe4a4a30f57bcd36bd1b3.jpg) | Add to Reading ListSource URL: resources.genomequest.comLanguage: English - Date: 2014-10-29 15:12:43
|
---|
24![Chahboun et al. BMC Biotechnology 2011, 11:113 http://www.biomedcentral.com[removed] RESEARCH ARTICLE Open Access Chahboun et al. BMC Biotechnology 2011, 11:113 http://www.biomedcentral.com[removed] RESEARCH ARTICLE Open Access](https://www.pdfsearch.io/img/55e1fbf9faeaa1c73592a5473d732f0f.jpg) | Add to Reading ListSource URL: www.antibotabe.comLanguage: English - Date: 2012-01-09 02:57:33
|
---|
25![Antibody engineering. December, 88-12, 2013. Huntington Beach, CA RECENT DEVELOPMENT OF ANTIBOTABE PROJECT: IDENTIFICATION OF NEUTRALIZING ANTIBODIES AGAINST BOTULINUM A,B AND E TOXINS Antibody engineering. December, 88-12, 2013. Huntington Beach, CA RECENT DEVELOPMENT OF ANTIBOTABE PROJECT: IDENTIFICATION OF NEUTRALIZING ANTIBODIES AGAINST BOTULINUM A,B AND E TOXINS](https://www.pdfsearch.io/img/0fcb1713965ced571dc4735d336acb4b.jpg) | Add to Reading ListSource URL: www.antibotabe.comLanguage: English - Date: 2013-12-05 09:05:15
|
---|
26![RECENT DEVELOPMENTS OF AntiBotABE PROJECT: IDENTIFICATION OF NEUTRALIZING scFvs and scFv-Fcs FUSION ANTIBODIES DIRECTED AGAINST BOTULINUM B TOXIN HEAVY AND LIGHT CHAIN Rasetti-Escargueil C*, Avril A, Tierney R., Bak N, M RECENT DEVELOPMENTS OF AntiBotABE PROJECT: IDENTIFICATION OF NEUTRALIZING scFvs and scFv-Fcs FUSION ANTIBODIES DIRECTED AGAINST BOTULINUM B TOXIN HEAVY AND LIGHT CHAIN Rasetti-Escargueil C*, Avril A, Tierney R., Bak N, M](https://www.pdfsearch.io/img/4f681b741477f1610eebdc6078045419.jpg) | Add to Reading ListSource URL: www.antibotabe.comLanguage: English - Date: 2014-11-11 13:14:11
|
---|
27![Microsoft Word - Pelat_CDDT.doc Microsoft Word - Pelat_CDDT.doc](https://www.pdfsearch.io/img/b6bfb12612ac4502b7d249dc469da6c9.jpg) | Add to Reading ListSource URL: www.antibotabe.comLanguage: English - Date: 2013-10-28 09:28:25
|
---|
28![BizCom Japan, Inc. and Fusion Antibodies Ltd Agreed Distribution and Marketing Agreement for services and products of Antibody Sequencing and Humanization in Japan BizCom Japan, Inc., a privately-held Japan-based trading BizCom Japan, Inc. and Fusion Antibodies Ltd Agreed Distribution and Marketing Agreement for services and products of Antibody Sequencing and Humanization in Japan BizCom Japan, Inc., a privately-held Japan-based trading](https://www.pdfsearch.io/img/37487017b274c7540abf0729ecbd8c4d.jpg) | Add to Reading ListSource URL: www.prweb.comLanguage: English - Date: 2014-01-13 03:00:41
|
---|
29![GENEURO INNOVATION SAS One line pitch: GeNeuro develops biotechnology treatments for disorders associated with endogenous retrovirus expression and presenting high unmet medical needs Market Analysis: GENEURO INNOVATION SAS One line pitch: GeNeuro develops biotechnology treatments for disorders associated with endogenous retrovirus expression and presenting high unmet medical needs Market Analysis:](https://www.pdfsearch.io/img/5a83c7f9e04b0942302bf61e9e551397.jpg) | Add to Reading ListSource URL: www.biovision.orgLanguage: English - Date: 2014-07-25 09:30:19
|
---|
30![Judgment rendered on May 30, [removed]Gyo-Ke[removed], Case of Seeking Rescission of a JPO Decision Date of conclusion of oral argument: February 24, 2014 Judgment Plaintiff: Genentech, Inc. Counsel attorney: YABE Kozo Judgment rendered on May 30, [removed]Gyo-Ke[removed], Case of Seeking Rescission of a JPO Decision Date of conclusion of oral argument: February 24, 2014 Judgment Plaintiff: Genentech, Inc. Counsel attorney: YABE Kozo](https://www.pdfsearch.io/img/088945f084fcf619b613b72c2daba364.jpg) | Add to Reading ListSource URL: www.ip.courts.go.jpLanguage: English - Date: 2014-10-06 22:02:45
|
---|